JENNIFER MCFARLAND: Open Payments
NPI 1659723823 · JACKSON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 30 payments from 10 companies in 2025. Trend: 2023 $5 · 2024 $318 · 2025 $575
Food & beverage: $575
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $142 |
| Alnylam Pharmaceuticals Inc. | 5 | $105 |
| Novo Nordisk Inc | 4 | $81 |
| BridgeBio Pharma, Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $43 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Abbott Laboratories | 1 | $20 |
| PFIZER INC. | 1 | $14 |
Products named: CAMZYOS, AMVUTTRA, Wegovy, Attruby, ELIQUIS, JARDIANCE, SHINGRIX, Kerendia.
Industry payments across TN — which companies pay providers there.
